Author's Reply

Affiliations

¹ College of Medicine and Public Health, Flinders University, Adelaide, Australia. Electronic address: michael.sorich@flinders.edu.au.
² College of Medicine and Public Health, Flinders University, Adelaide, Australia.
³ College of Medicine and Public Health, Flinders University, Adelaide, Australia; Department of Medical Oncology, Flinders Medical Centre, Adelaide, Australia.

Free article

Comment

Michael J Sorich et al. J Thorac Oncol. 2019 Sep.

Free article

. 2019 Sep;14(9):e210.

doi: 10.1016/j.jtho.2019.07.009.

¹ College of Medicine and Public Health, Flinders University, Adelaide, Australia. Electronic address: michael.sorich@flinders.edu.au.
² College of Medicine and Public Health, Flinders University, Adelaide, Australia.
³ College of Medicine and Public Health, Flinders University, Adelaide, Australia; Department of Medical Oncology, Flinders Medical Centre, Adelaide, Australia.

No abstract available

Comment on

Evaluation of the Lung Immune Prognostic Index for Prediction of Survival and Response in Patients Treated With Atezolizumab for NSCLC: Pooled Analysis of Clinical Trials.
Sorich MJ, Rowland A, Karapetis CS, Hopkins AM. Sorich MJ, et al. J Thorac Oncol. 2019 Aug;14(8):1440-1446. doi: 10.1016/j.jtho.2019.04.006. Epub 2019 Apr 15. J Thorac Oncol. 2019. PMID: 30999110
Letter to the Editor about Sorich et al.
Mezquita L, Auclin E, Besse B. Mezquita L, et al. J Thorac Oncol. 2019 Sep;14(9):e209. doi: 10.1016/j.jtho.2019.05.022. J Thorac Oncol. 2019. PMID: 31445741 No abstract available.